SAVE THE DATE
29 September 2026
4pm CET, 3pm UK, 10am EST
Francisca Silva (PAREA)
https://parea.eu/
SAVE THE DATE
21 October 2026
4pm CET, 3pm UK, 10am EST
MDMA: Becond Ecstasy
On the report by the Dutch State Commission
Wim van den Brink
(vice chair of the Dutch State Commission on MDMA)
https://www.government.nl/documents/2024/05/31/mdma-beyond-ecstasy
Salon#2:
10 June 2026
4pm CET, 3pm UK, 10am EST
A regulatory sandbox for psychedelics
Christoph Bublitz
The input will present ideas for a future regulatory framework for psychedelic-assisted medicine that responds to some of the challenges raised in the MDMA-AT approval process, at conferences, and in the literature, such as: the unspecific labelling of the drug; the combination of drug and therapy, which fall under quite different legal regimes; and novel risks arising from psychedelic effects in the absence of clear ethical guidance. The proposed solution is a so-called regulatory sandbox — a temporary and adaptive regulatory system to bridge the period until problems are better understood, best practices have been established, and ethical norms consolidated.
Salon#1
6 May 2026
4pm CET, 3pm UK, 10am EST
From Prohibition to Rational Regulation: The Czech Drug Policy Experiment and a Blueprint for Reform.
Jitka Nykodemová
The talk is followed by a general discussion among saloners on the state of the field of psychedelics and law. Psychedelics and the Law: Where Are We Now & Where Are We Going?
The talk presents the Czech Republic’s pioneering legislative reforms in drug policy – including the strictly regulated legal market for non-medical psychoactive substances (“psychomodulatory substances”), cannabis legalisation progress, and medical psilocybin – as a concrete, replicable alternative to the global prohibition paradigm. It examines how evidence-based, human rights-grounded approaches were translated into national law within existing international legal frameworks, and what other countries and EU Member States can draw from this example.